EUVIMEDEUVIMED entdecken
Crossref

Anticancer effects of Commiphora myrrha extract on colorectal cancer through regulation of metastasis, cell cycle progression, and apoptosis in vitro and in vivo

Ju-Huei Chien, Kai-Fu Chang, Yu-Chi Chen, Ming-Chang Hsieh, Nu-Man Tsai

Medical Oncology · 2025

DOI: 10.1007/s12032-025-03050-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2025. Verfasst von Ju-Huei Chien und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Taichung Tzu-Chi Hospital, Buddhist Tzu-Chi Medical Foundation, Taichung, 42743, Taiwan, ROC. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Apoptosis, Plant Extracts, Commiphora. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Taichung Tzu Chi Hospital, Chung Shan Medical University Hospital Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Commiphora myrrha exhibits multiple pharmacological properties, including antioxidant, anti-inflammatory, antimicrobial, antidiabetic, and anticancer activities. Although the cytotoxic effects of C. myrrha have been observed in various cancer cell lines, the molecular mechanisms underlying its therapeutic potential against colorectal cancer (CRC) remain largely uncharacterized. In this study, we investigated the anticancer effects of C. myrrha extract (CMy) on CRC using in vitro and in vivo models. The anticancer properties of CMy were evaluated through MTT assay, colony formation, wound healing assay, invasion assay, cell cycle analysis, and terminal deoxynucleotidyl transferase dUTP nick-end labeling staining. Western blotting was performed to detect the expression of proteins associated with cell cycle progression and apoptosis. The in vivo antitumor efficacy of CMy was investigated in a CRC-bearing BALB/c mouse model. This study revealed that CMy significantly decreased the viability, colony-forming ability, and the migratory and invasive capacities of CRC cells. Mechanistically, CMy induced G0/G1 phase cell cycle arrest through the downregulation of cyclin-dependent kinase 4 and cyclin D1 and promoted apoptosis by upregulating pro-apoptotic markers, including Bcl-2-associated X, caspase-9, and caspase-3. Furthermore, CMy exhibited a synergistic cytotoxic effect when combined with 5-fluorouracil, thereby enhancing its inhibitory activity against CRC cells. In vivo, CMy treatment effectively suppressed tumor progression and prolonged the survival of tumor-bearing mice at well-tolerated doses. Collectively, these findings indicate that CMy is a promising source of cytotoxic phytochemicals with significant anti-CRC activity, supporting its potential application as a therapeutic agent for CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsApoptosisPlant ExtractsCommiphoraAnimalsHumansMice, Inbred BALB CMiceXenograft Model Antitumor AssaysCell Line, TumorCell CycleCell ProliferationCell MovementMice, Nude

Stichwörter der Autor:innen

Commiphora myrrhaApoptosisCell cycle progressionColorectal cancerCombination treatment

Substanzen

Plant Extracts

Autor:innen und Institutionen

  • Department of Research, Taichung Tzu-Chi Hospital, Buddhist Tzu-Chi Medical Foundation, Taichung, 42743, Taiwan, ROC.
  • Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, No.110, Sec.1, Jianguo N. Rd., Taichung, 40201, Taiwan, ROC.
  • Clinical Laboratory, Chung Shan Medical University Hospital, Taichung, 40201, Taiwan, ROC.
  • Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, No.110, Sec.1, Jianguo N. Rd., Taichung, 40201, Taiwan, ROC. numan@csmu.edu.tw.
  • Clinical Laboratory, Chung Shan Medical University Hospital, Taichung, 40201, Taiwan, ROC. numan@csmu.edu.tw.
  • Department of Life-and-Death Studies, Nanhua University, Chiayi, 62249, Taiwan, ROC. numan@csmu.edu.tw.

Förderung

  • Taichung Tzu Chi Hospital
  • Chung Shan Medical University Hospital Foundation

Zitieren

APA

Chien, J. H., Chang, K. F., Chen, Y. C., Hsieh, M. C., & Tsai, N. M. (2025). Anticancer effects of Commiphora myrrha extract on colorectal cancer through regulation of metastasis, cell cycle progression, and apoptosis in vitro and in vivo. Medical Oncology. https://doi.org/10.1007/s12032-025-03050-3

Vancouver

Chien JH, Chang KF, Chen YC, Hsieh MC, Tsai NM. Anticancer effects of Commiphora myrrha extract on colorectal cancer through regulation of metastasis, cell cycle progression, and apoptosis in vitro and in vivo. Medical Oncology. 2025. doi:10.1007/s12032-025-03050-3

BibTeX
@article{Chien2025,
  author = {Chien, Ju-Huei and Chang, Kai-Fu and Chen, Yu-Chi and Hsieh, Ming-Chang and Tsai, Nu-Man},
  title = {Anticancer effects of Commiphora myrrha extract on colorectal cancer through regulation of metastasis, cell cycle progression, and apoptosis in vitro and in vivo},
  journal = {Medical Oncology},
  year = {2025},
  doi = {10.1007/s12032-025-03050-3}
}
Kostenlos starten →